↓ Skip to main content

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
4 X users

Citations

dimensions_citation
139 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
Published in
Journal for Immunotherapy of Cancer, June 2019
DOI 10.1186/s40425-019-0634-9
Pubmed ID
Authors

Mathieu Grapin, Corentin Richard, Emeric Limagne, Romain Boidot, Véronique Morgand, Aurélie Bertaut, Valentin Derangere, Pierre-Antoine Laurent, Marion Thibaudin, Jean David Fumet, Gilles Crehange, François Ghiringhelli, Céline Mirjolet

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 17 18%
Student > Master 13 14%
Other 10 11%
Student > Ph. D. Student 8 9%
Student > Doctoral Student 7 7%
Other 10 11%
Unknown 29 31%
Readers by discipline Count As %
Medicine and Dentistry 22 23%
Biochemistry, Genetics and Molecular Biology 17 18%
Immunology and Microbiology 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Agricultural and Biological Sciences 2 2%
Other 5 5%
Unknown 36 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 July 2019.
All research outputs
#15,100,333
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,470
of 3,424 outputs
Outputs of similar age
#188,624
of 366,273 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#75
of 87 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,273 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.